메뉴 건너뛰기




Volumn 104, Issue 7, 2015, Pages 582-590

Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis

Author keywords

Anticoagulants; Cardioversion; Electric countershock; Meta analysis; Stroke; Transesophageal echocardiography

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; RIVAROXABAN; VITAMIN K GROUP;

EID: 84933177794     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-015-0821-8     Document Type: Article
Times cited : (26)

References (38)
  • 2
    • 0014470842 scopus 로고
    • The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
    • COI: 1:STN:280:DyaF1M7jtVKkuw%3D%3D, PID: 4180019
    • Bjerkelund CJ, Orning OM (1969) The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 23:208–216
    • (1969) Am J Cardiol , vol.23 , pp. 208-216
    • Bjerkelund, C.J.1    Orning, O.M.2
  • 4
    • 84939887233 scopus 로고    scopus 로고
    • Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
    • PID: 25119841
    • Caldeira D, Barra M, Pinto FJ, Ferreira JJ, Costa J (2014) Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis. J Neurol. doi:10.1007/s00415-014-7462-0
    • (2014) J Neurol
    • Caldeira, D.1    Barra, M.2    Pinto, F.J.3    Ferreira, J.J.4    Costa, J.5
  • 5
    • 84875912864 scopus 로고    scopus 로고
    • General mechanisms of coagulation and targets of anticoagulants (section I). Position Paper of the ESC working group on thrombosis-task force on anticoagulants in heart disease
    • De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013) General mechanisms of coagulation and targets of anticoagulants (section I). Position Paper of the ESC working group on thrombosis-task force on anticoagulants in heart disease. Thromb Haemost 109:569–579
    • (2013) Thromb Haemost , vol.109 , pp. 569-579
  • 6
    • 84896544335 scopus 로고    scopus 로고
    • Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
    • COI: 1:CAS:528:DC%2BC2cXpsFent7k%3D, PID: 24476812
    • Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira JJ, Costa J (2014) Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis. Heart 100:550–556
    • (2014) Heart , vol.100 , pp. 550-556
    • Caldeira, D.1    Barra, M.2    Santos, A.T.3    de Abreu, D.4    Pinto, F.J.5    Ferreira, J.J.6    Costa, J.7
  • 8
    • 84899764653 scopus 로고    scopus 로고
    • Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis
    • PID: 24577485
    • Skjøth F, Larsen TB, Rasmussen LH, Lip GY (2014) Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis. Thromb Haemost 111:981–988
    • (2014) Thromb Haemost , vol.111 , pp. 981-988
    • Skjøth, F.1    Larsen, T.B.2    Rasmussen, L.H.3    Lip, G.Y.4
  • 9
    • 84894088687 scopus 로고    scopus 로고
    • The risk of infection with new oral anticoagulants: a meta-analysis
    • PID: 24447759
    • Caldeira D, Costa J, Pinto FJ, Ferreira JJ (2014) The risk of infection with new oral anticoagulants: a meta-analysis. Int J Cardiol 172:267–268
    • (2014) Int J Cardiol , vol.172 , pp. 267-268
    • Caldeira, D.1    Costa, J.2    Pinto, F.J.3    Ferreira, J.J.4
  • 10
    • 84934277855 scopus 로고    scopus 로고
    • Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
    • PID: 25416564
    • Nielsen PB, Lane DA, Rasmussen LH, Lip GY, Larsen TB (2014) Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. Clin Res Cardiol. doi:10.1007/s00392-014-0797-9
    • (2014) Clin Res Cardiol
    • Nielsen, P.B.1    Lane, D.A.2    Rasmussen, L.H.3    Lip, G.Y.4    Larsen, T.B.5
  • 11
    • 68549101842 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
    • PID: 19622552
    • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. doi:10.1136/bmj.b2700
    • (2009) BMJ , vol.339 , pp. 2700
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3    Mulrow, C.4    Gøtzsche, P.C.5    Ioannidis, J.P.6    Clarke, M.7    Devereaux, P.J.8    Kleijnen, J.9    Moher, D.10
  • 12
    • 84933184703 scopus 로고    scopus 로고
    • Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Accessed in Sep 2014
    • Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.cochrane-handbook.org. Accessed in Sep 2014
  • 13
    • 0022992740 scopus 로고
    • Meta-analysis in clinical trials
    • COI: 1:STN:280:DyaL2s7gsVamtA%3D%3D, PID: 3802833
    • DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
    • (1986) Control Clin Trials , vol.7 , pp. 177-188
    • DerSimonian, R.1    Laird, N.2
  • 14
    • 0037098201 scopus 로고    scopus 로고
    • Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes
    • PID: 12111921
    • Deeks JJ (2002) Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 21:1575–1600
    • (2002) Stat Med , vol.21 , pp. 1575-1600
    • Deeks, J.J.1
  • 15
    • 84962823669 scopus 로고    scopus 로고
    • Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publication Group, London
    • Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publication Group, London, pp 313–335
    • (2001) pp 313–335
    • Deeks, J.J.1    Altman, D.G.2    Bradburn, M.J.3
  • 16
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • COI: 1:STN:280:DyaK2svls1KjtA%3D%3D, PID: 9310563
    • Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 17
    • 32144440794 scopus 로고    scopus 로고
    • Comparison of two methods to detect publication bias in meta-analysis
    • COI: 1:CAS:528:DC%2BD28XhtF2qsrw%3D, PID: 16467236
    • Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–680
    • (2006) JAMA , vol.295 , pp. 676-680
    • Peters, J.L.1    Sutton, A.J.2    Jones, D.R.3    Abrams, K.R.4    Rushton, L.5
  • 22
    • 33846260745 scopus 로고    scopus 로고
    • Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
    • PID: 16596572
    • Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A (2007) Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 26:53–77
    • (2007) Stat Med , vol.26 , pp. 53-77
    • Bradburn, M.J.1    Deeks, J.J.2    Berlin, J.A.3    Russell Localio, A.4
  • 23
    • 84933184705 scopus 로고    scopus 로고
    • Deeks JJ, Higgins JPT, Altman DG (2011) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Accessed in Sep 2014
    • Deeks JJ, Higgins JPT, Altman DG (2011) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.cochrane-handbook.org. Accessed in Sep 2014
  • 24
    • 84933184706 scopus 로고    scopus 로고
    • Higgins JPT, Deeks JJ, Altman DG (2011) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (eds), Cochrane Handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Accessed in Sep 2014
    • Higgins JPT, Deeks JJ, Altman DG (2011) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (eds), Cochrane Handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.cochrane-handbook.org. Accessed in Sep 2014
  • 25
    • 84890730197 scopus 로고    scopus 로고
    • Sterne JAC, Egger M, Moher D (2011) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (eds) Cochrane Handbook for systematic reviews of intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Accessed in Sep 2014
    • Sterne JAC, Egger M, Moher D (2011) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (eds) Cochrane Handbook for systematic reviews of intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.cochrane-handbook.org. Accessed in Sep 2014
  • 26
    • 0026532168 scopus 로고
    • Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
    • COI: 1:STN:280:DyaK387osFWgsw%3D%3D, PID: 1545081
    • Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG (1992) Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 19:851–855
    • (1992) J Am Coll Cardiol , vol.19 , pp. 851-855
    • Arnold, A.Z.1    Mick, M.J.2    Mazurek, R.P.3    Loop, F.D.4    Trohman, R.G.5
  • 27
    • 77957738116 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 12:1360–1420
    • (2010) Europace , vol.12 , pp. 1360-1420
  • 28
    • 0032535059 scopus 로고    scopus 로고
    • Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis
    • COI: 1:STN:280:DyaK1M%2FovFClsA%3D%3D, PID: 9874066
    • Berger M, Schweitzer P (1998) Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol 82:1545–1547
    • (1998) Am J Cardiol , vol.82 , pp. 1545-1547
    • Berger, M.1    Schweitzer, P.2
  • 29
    • 3242673551 scopus 로고    scopus 로고
    • Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion
    • COI: 1:STN:280:DC%2BD2czhvVGnuw%3D%3D, PID: 15219540
    • Corrado G, Beretta S, Sormani L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Santarone M (2004) Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion. Eur J Echocardiogr 5:257–261
    • (2004) Eur J Echocardiogr , vol.5 , pp. 257-261
    • Corrado, G.1    Beretta, S.2    Sormani, L.3    Tadeo, G.4    Foglia-Manzillo, G.5    Tagliagambe, L.M.6    Santarone, M.7
  • 31
    • 84909977526 scopus 로고    scopus 로고
    • Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: do newcomers improve outcomes? Insights from a meta-analysis of RCTs
    • Caldeira D, Costa J, Ferreira JJ, Pinto FJ (2014) Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: do newcomers improve outcomes? Insights from a meta-analysis of RCTs. Int J Cardiol. doi:10.1016/j.ijcard.2014.09.099
    • (2014) Int J Cardiol
    • Caldeira, D.1    Costa, J.2    Ferreira, J.J.3    Pinto, F.J.4
  • 32
    • 84877301336 scopus 로고    scopus 로고
    • European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
    • PID: 23625942
    • Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P, European Heart Rhythm Association (2013) European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 15:625–651
    • (2013) Europace. , vol.15 , pp. 625-651
    • Heidbuchel, H.1    Verhamme, P.2    Alings, M.3    Antz, M.4    Hacke, W.5    Oldgren, J.6    Sinnaeve, P.7    Camm, A.J.8    Kirchhof, P.9
  • 33
    • 84897025115 scopus 로고    scopus 로고
    • Drug adherence in patients taking oral anticoagulation therapy
    • COI: 1:CAS:528:DC%2BC3sXhtlyisLbO, PID: 23999974
    • Ewen S, Rettig-Ewen V, Mahfoud F, Böhm M, Laufs U (2014) Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol 103:173–182
    • (2014) Clin Res Cardiol , vol.103 , pp. 173-182
    • Ewen, S.1    Rettig-Ewen, V.2    Mahfoud, F.3    Böhm, M.4    Laufs, U.5
  • 34
    • 84908317338 scopus 로고    scopus 로고
    • The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis
    • PID: 25070671
    • Caldeira D, Vaz-Carneiro A, Costa J (2014) The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis. Rev Port Cardiol 33:431–437
    • (2014) Rev Port Cardiol , vol.33 , pp. 431-437
    • Caldeira, D.1    Vaz-Carneiro, A.2    Costa, J.3
  • 35
    • 84902665694 scopus 로고    scopus 로고
    • Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria
    • PID: 24911432
    • Clemens A, Noack H, Brueckmann M, Lip GY (2014) Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria. PLoS One 9:e99276
    • (2014) PLoS One , vol.9 , pp. 99276
    • Clemens, A.1    Noack, H.2    Brueckmann, M.3    Lip, G.Y.4
  • 36
    • 84897449184 scopus 로고    scopus 로고
    • Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter
    • COI: 1:CAS:528:DC%2BC2cXjsVKksb0%3D, PID: 24576547
    • Yadlapati A, Groh C, Passman R (2014) Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter. Am J Cardiol 113:1362–1363
    • (2014) Am J Cardiol , vol.113 , pp. 1362-1363
    • Yadlapati, A.1    Groh, C.2    Passman, R.3
  • 37
    • 84933184708 scopus 로고    scopus 로고
    • Edoxaban vs. Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF). ClinicalTrials.gov Identifier: NCT02072434. Accessed in Sep 2014
    • Edoxaban vs. Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF). ClinicalTrials.gov Identifier: NCT02072434. http://clinicaltrials.gov/show/NCT02072434. Accessed in Sep 2014
  • 38
    • 84933184709 scopus 로고    scopus 로고
    • Study of the blood thinner, apixaban, for patients who have an abnormal heart rhythm (atrial fibrillation) and expected to have treatment to put them back into a normal heart rhythm (cardioversion) (EMANATE). ClinicalTrials.gov Identifier: NCT02100228. Accessed in Sep 2014
    • Study of the blood thinner, apixaban, for patients who have an abnormal heart rhythm (atrial fibrillation) and expected to have treatment to put them back into a normal heart rhythm (cardioversion) (EMANATE). ClinicalTrials.gov Identifier: NCT02100228. http://clinicaltrials.gov/show/NCT02100228. Accessed in Sep 2014


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.